In fact, Liu Sihui is now under a lot of pressure. The company's previous business has been in a state of loss. Now that Future Medicine has taken over, the situation has not improved, but the business volume has plummeted!

Now we are losing more than 5 million soft sister coins every month, and this is the expenditure after streamlining the staff. A few years ago, the monthly expenditure would have been several million more!

Therefore, the future of the entire company is placed on Chen Can.

Everyone knows how much money and time it takes to wait for a new drug to go from experimentation to marketing approval.

Can't afford it!

In fact, Nova Company had already investigated these situations clearly, so they arrived belatedly and only asked the vice president of one branch to come to negotiate.

From the perspective of Novavax, this future pharmaceutical company will not last long at all. The reason why it is still willing to pay 100 million US dollars to acquire it is very simple.

The potential of this new drug "Shuguang" is really great!

In this world, there is not only one pharmaceutical giant, Novavax, but there are too many pharmaceutical giants around the world.

If other pharmaceutical giants find out that there is an anti-cancer drug that is more effective than melinin, and that they have spared all the patents on melinin, it is a brand-new research, the consequences will be unimaginable!

Therefore, they are also afraid of beating the odds, and try their best to offer 100 million US dollars to acquire the company when future medicines can still be discussed.

However, Nova was greatly disappointed with the first contact.

The calmness of future medicine makes them hesitate.

Chen Can naturally does not plan to sell the drug "Shuguang". This is Cheng Yong's regret. Even if he does not make money, he still has to put this drug on the market!

But now, future medicine is indeed encountering difficulties!

Chen Can also felt that there was an unprecedented resistance that was preventing "Shuguang" from moving to the next step!

It's a pity that this is not a generic drug, but a serious innovative drug, and it must follow the formal process!

And what some people are stuck on is your formal process.

If Chen Can were really just an ordinary person, he might end up struggling for a year and a half before finally choosing to bow his head and admit defeat. At most, he would just sell Shuguang for a good price!

But Chen Can is not!

In fact, when he decided to develop the drug "Shuguang", Chen Can knew the difficulties and pressure he would face next.

But now that he has decided to show his sword, it will no longer be a small fight, and Chen Can is not prepared to act according to the rules with other pharmaceutical companies. His rules are the rules!

Chen Can has been spending time in the laboratory these days. Instead of continuing to study "Dawn", he is studying a virus that is extremely contagious!

2003 is a special year!

Now that we have decided to show off our sword in the pharmaceutical industry, we cannot avoid the special year of 2003!

Within the next half month, Novavax once again sent a negotiation team, this time with the vice president of the Asia-Pacific region.

The other party was quite sincere and directly offered $300 million!

Liu Sihui was still doing Tai Chi and acted very calmly, and the two sides broke up on bad terms again!

Finally, one day at the end of April, Chen Can walked out of the laboratory looking a little tired, but with a hint of relief between his brows!

Looking at the rainbow after the rain in the distance, Chen Can knew that in the future of medicine, the resistance ahead would be completely over today!

I sent a message to Liu Sihui, and the two of them spent a sleepless night at Chen Can's accommodation!

After a night, Chen Can felt refreshed and returned to the laboratory.

The next day, a medical team settled in Future Medicine and took over the entire research and development department of Future Medicine.

Three days later, a family flew directly to Beijing!

Half a month later, a certain State-owned Assets Supervision and Administration Commission officially invested one billion soft sister coins in Future Medicine, accounting for 20% of the shares!

It was on this day that "Future Medicine" officially launched its attack!

At the same time, Sugon's clinical trial application was approved, and the clinical phase I trial has been fully launched!

At the same time, the global patent application was officially launched. This time, with the endorsement of the Chinese government and sufficient financial support, the next obstacles are no longer difficult!

In June, clinical phase II trials began, and hundreds of chronic myelogenous leukemia patients around the world underwent clinical phase II trials!

Among them, Lu Yiyi and Huang Mao were among the first batch of experimental subjects.

When the preliminary experimental results came out a month later, the efficacy of this drug was beyond imagination. It almost completely inhibited the growth of cancer cells. This drug completely subverted everyone's understanding and the entire medical community was shocked.

!

The clinical phase III trial further confirmed the efficacy of Sugon. Almost at the same time, Future Medicine officially launched Sugon's marketing application to the relevant departments.

With the official endorsement, approval process, and green light all the way, Shuguang was finally approved for listing on April 14, 2004!

It took one year and two months from research and development to approval for marketing. This speed shocked all peers!

Of course, the only country that has approved Sugon’s listing application is China.

Nova Corporation will not give up easily!

They began to sue Future Pharmaceutical Company all over the world, and carried out various slanders against the new drug Shuguang. At the same time, their public relations team began to spend money lavishly, and began to encircle Future Pharmaceutical Company in an all-round way!

But Chen Can naturally has a way to force Nova Corporation to retreat!

When Future Medicine held a press conference, it was directly announced at the press conference that the price of Shuguang in the Chinese market was "1,860 yuan" per bottle.

And a series of data have been published, proving the safety of this drug. Each patient only needs to take one bottle of medicine every two months, and its efficacy is several times that of glenin. It is almost a perfect anti-inflammatory drug.

Cancer medicine!

The news about Shuguang’s price and efficacy spread rapidly through the press conference!

This news quickly appeared on major news media platforms. With Chen Can's help, the chronic myelogenous leukemia group was completely exposed to everyone.

From being unable to survive to finding real hope, news stories like this completely ignited the entire Internet.

Future Medicine, a unique pharmaceutical company, also made its first real appearance, and many people also deeply remembered this different company!

At the same time, news about Sugon's new drug spread quickly to all parts of the world on the Internet, especially chronic myelogenous leukemia patients around the world. After seeing this news, they were encouraged. They are all looking forward to Sugon as soon as possible.

On sale in their country!

But obviously, with the exception of China, marketing approval in other countries is still far away.

The lawsuit between Mirae Pharmaceuticals and Novavax was completely exposed under such circumstances.

Although Nova's public relations department tried its best to suppress the news about Sugon, with the help of the Internet, it completely lost control.

Almost all chronic myelogenous leukemia patients in the world know that China has a new drug called "Shuguang", which is low-priced and has several times the efficacy of glenin produced by Novavax.

Novavax, for the sake of profit, regardless of the life and death of patients, chose to block Sugon's listing!

Although capital is in power in the West, their so-called human fist is on the surface!

Nova Corporation has been subjected to countless criticisms for a while, and those who endorsed Nova Corporation are as uncomfortable as eating flies at this moment!

Against this background, after a two-year legal battle, Novavax lost the case. Future Medicines also officially obtained a patent and passed the approval for listing in various countries.

The emergence of "Dawn" can be said to have completely changed the disease of chronic myelogenous leukemia. It is no longer a source of fear for patients and a nightmare for countless families.

A bottle costs 1,860 yuan and can be taken for two months. The monthly cost of medicine is less than 1,000 yuan. The most important thing is that this medicine is quickly included in medical insurance, and most families can already afford it!

After completing the listing of "Shuguang", Chen Can took a break for half a year, traveled to various places and had a lot of fun before going back to work.

At the moment when he completed his mission, Chen Can felt that Cheng Yong's soul in his body seemed to be complete.

He had a feeling that if he chose to end the mission and leave this world, his score would be at least ninety-five, or even higher!

But Chen Can obviously won't leave this world right away.

Now that Future Medicine has opened up everything, after completing Cheng Yong's mission, this world will be its real testing ground.
Chapter completed!